EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial

Philipp Krisai iD, Emilie P Belley-Cote, William F McIntyre, Jorge Wong, Kate Tsiplova, Katheryn Brady, Philip Joseph, Isabelle Johansson, Linda Johnson, Lucas Yixi Xing, Andrea Colli, Shay McGuinness und 10 weitere

European Journal of Heart Failure · 2025

DOI: 10.1002/ejhf.3536 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Philipp Krisai und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cardiac Surgical Procedures, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The left atrial appendage (LAA) produces natriuretic peptides and its removal or occlusion might increase the risk of heart failure (HF). We aimed to investigate the incidence of HF after LAA occlusion or removal (LAAO) in the Left Atrial Appendage Occlusion Study (LAAOS III). Methods and results Patients (n = 4811) with atrial fibrillation (AF) and a CHA2DS2-VASc score ≥2, who were having cardiac surgery for another indication, were randomized to undergo surgical LAAO or not. We compared the composite outcome of HF-related hospitalizations and HF death between the two groups. HF assessment required clinical and radiographic evidence of HF. Analyses included a landmark analysis before and after 30 days and subgroups. Mean age was 71.2 years, 67.5% were male and 57.0% had prior HF. Over a mean follow-up of 3.8 years, 396 (8.3%) patients met the composite HF outcome: 209 (8.8%) with LAAO (n = 2379) and 187 (7.8%) without LAAO (n = 2391) (hazard ratio [HR] 1.12, 95% confidence interval [CI] 0.92–1.37, p = 0.25). There was no difference between the two groups in the first 30 days (1.6% vs. 1.1%; p = 0.12) and thereafter (7.6% vs. 7.1%; p = 0.57). Subgroups based on age, sex, body mass index, AF type, prior HF, cardiac rhythm or left ventricular ejection fraction showed consistent results. There was no difference in HF outcomes with LAAO between the cut-and-sew (HR 0.93, 95% CI 0.70–1.23, p = 0.62) versus other closure methods (HR 1.05, 95% CI 0.77–1.41, p = 0.77).

Conclusions

Left atrial appendage occlusion or removal at the time of cardiac surgery does not appear to alter the risk of HF-related hospitalization or death. Clinical Trial Registration: ClinicalTrials.gov NCT01561651.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationCardiac Surgical ProceduresHeart FailurePostoperative ComplicationsAgedFemaleHumansMaleFollow-Up StudiesIncidenceRisk FactorsStroke Volume

Stichwörter der Autor:innen

Atrial fibrillationHeart failureLeft atrial appendageLeft atrial appendage occlusion

Autor:innen und Institutionen

  • Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
  • McMaster University, Hamilton, ON, Canada.
  • Hamilton Health Sciences, Hamilton, ON, Canada.
  • Population Health Research Institute, Hamilton, ON, Canada.
  • Division of Cardiology, Department of Medicine K2, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

ORCID-Profile: Philipp Krisai

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Krisai, P., Belley-Cote, E. P., McIntyre, W. F., Wong, J., Tsiplova, K., Brady, K., Joseph, P., Johansson, I., Johnson, L., Xing, L. Y., Colli, A., McGuinness, S., Punjabi, P., Reents, W., Rega, F., Budera, P., Royse, A. G., Paparella, D., Connolly, S., …, & on behalf of the LAAOS III Investigators (2025). Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3536

Vancouver

Krisai P, Belley-Cote EP, McIntyre WF, Wong J, Tsiplova K, Brady K, et al. Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3536

BibTeX
@article{Krisai2025,
  author = {Krisai, Philipp and Belley-Cote, Emilie P and McIntyre, William F and Wong, Jorge and Tsiplova, Kate and Brady, Katheryn and Joseph, Philip and Johansson, Isabelle and Johnson, Linda and Xing, Lucas Yixi and Colli, Andrea and McGuinness, Shay and Punjabi, Prakash and Reents, Wilko and Rega, Filip and Budera, Petr and Royse, Alistair G and Paparella, Domenico and Connolly, Stuart and Whitlock, Richard P and Healey, Jeff S and on behalf of the LAAOS III Investigators, on behalf of the LAAOS III Investigators},
  title = {Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial},
  journal = {European Journal of Heart Failure},
  year = {2025},
  doi = {10.1002/ejhf.3536}
}
Kostenlos starten →